Peptide Mass Spectrometry: How to Read an MS Identity Result

How to read a peptide mass spectrometry result: calculating expected mass, [M+H]+ and charge states, adduct and impurity peaks, tolerance, and what MS cannot tell you about purity or content.

In short

Peptide mass spectrometry confirms identity by measuring mass-to-charge ratio (m/z), not purity. To read a result, calculate the expected monoisotopic mass from the sequence, add one proton for [M+H]+ (or divide by the charge state for [M+nH]n+), and check that the observed peak falls within the stated tolerance. Extra peaks at predictable mass shifts point to adducts, oxidation or synthesis by-products.

Holiday sale: every research compound is buy one, get one free through December 25, 2026 — sitewide, unlimited, applied automatically at checkout. See how it works.

A certificate of analysis usually leads with an HPLC purity figure, but purity and identity are different questions. HPLC tells you how much of the UV-absorbing material elutes as one main peak. It does not tell you that the main peak is the peptide on the label. That is the job of mass spectrometry (MS). This guide explains what a peptide mass spectrometry result actually reports, how to check it against the sequence yourself, and which extra peaks are routine versus worth a question. If you have not read it yet, our companion guide on how to read a peptide COA covers the HPLC and endotoxin sections of the same document.

What does peptide mass spectrometry measure?

A mass spectrometer measures the mass-to-charge ratio (m/z) of ions, not the mass of neutral molecules. The peptide has to be given a charge first, almost always by adding one or more protons, and the instrument then sorts ions by m/z.

Two ionisation methods dominate peptide work:

  • Electrospray ionisation (ESI), usually coupled to liquid chromatography as LC-MS. ESI tends to produce a series of multiply charged ions, [M+2H]2+, [M+3H]3+ and so on, which is what made it practical for large biomolecules (Fenn et al., 1989).
  • Matrix-assisted laser desorption/ionisation (MALDI), usually with a time-of-flight analyser. MALDI mostly produces singly charged [M+H]+ ions, so the spectrum is simpler to read by eye (Karas & Hillenkamp, 1988).

Either way, the result is a confirmation that a molecule of the expected mass is present. On its own it is not a quantity and not a purity value.

How do you calculate the expected mass of a peptide?

Sum the residue masses of every amino acid in the sequence, then add the mass of one water molecule for the free termini. Use monoisotopic masses when the instrument resolves isotopes (most modern ESI and MALDI instruments do for small peptides) and average masses when it does not.

A worked example with BPC-157, sequence GEPPPGKPADDAGLV (15 residues), calculated from standard residue masses:

Quantity Value How it is derived
Monoisotopic mass (M) 1418.70 Da Sum of monoisotopic residue masses + H2O (18.011)
Average mass 1419.55 Da Same, using average (isotope-weighted) masses
[M+H]+ m/z 1419.71 M + 1.007 (one proton)
[M+2H]2+ m/z 710.36 (M + 2 × 1.007) ÷ 2
[M+3H]3+ m/z 473.91 (M + 3 × 1.007) ÷ 3
[M+Na]+ m/z 1441.69 M + 22.990 (sodium instead of a proton)

The general rule is m/z = (M + n × 1.00728) ÷ n, where n is the number of protons added. Modifications change M before you start: a C-terminal amide subtracts 0.984 Da, each disulfide bond subtracts 2.016 Da, and an N-terminal acetyl adds 42.011 Da. For more on how sequence, salt form and molecular weight relate, see our guide to peptide molecular weight and net peptide content.

Why does a mass spec show several peaks for one peptide?

Because one peptide produces several ions. Seeing more than one peak is normal and, read correctly, it strengthens the identification rather than weakening it.

  1. Charge states. In ESI, the same molecule appears at m/z values for 2+, 3+ and sometimes 4+. Deconvoluting them should give one consistent neutral mass.
  2. Isotope envelope. Carbon-13 and other heavy isotopes create a cluster of peaks. For a singly charged ion they are about 1 unit apart; for a 2+ ion, about 0.5 apart. The spacing is a quick way to read the charge.
  3. Adducts. Sodium (+21.982 relative to [M+H]+) and potassium (+37.956) adducts are common, especially from glassware and buffers. Trifluoroacetic acid, used in purification, can also appear as a +114 adduct. These are well-documented background signals (Keller et al., 2008).
  4. In-source fragments. Labile bonds can break inside the ion source, giving smaller peaks that are not present in the vial.

Which mass shifts point to impurities or degradation?

Peaks that differ from the expected mass by the mass of a specific chemical change are the ones worth reading closely. Synthetic peptide impurities fall into recognisable classes, reviewed in detail by D’Hondt et al. (2014).

Observed shift from M Likely explanation
−(one residue mass), e.g. −57.02 (Gly), −97.05 (Pro) Deletion sequence from an incomplete coupling step
+(one residue mass) Insertion sequence (double coupling)
+15.995 (or +31.990) Oxidation, typically methionine or tryptophan
+0.984 Deamidation of asparagine or glutamine
−18.011 Water loss, e.g. aspartimide or pyroglutamate formation
Large positive shifts (e.g. +56, +96, +252) Incompletely removed protecting groups (tBu, TFA ester, Pbf)

A deamidated peptide differs by less than one dalton, so it sits inside the isotope envelope of the parent at low resolution. That is one reason a mass check and an HPLC purity check complement each other: deamidated and isomerised forms often separate chromatographically even when their masses barely differ. Our peptide storage and degradation guide covers how oxidation and deamidation arise after manufacture.

What does “observed mass within tolerance” mean on a COA?

It means the measured mass matched the theoretical mass within an accuracy window the lab set in advance. That window depends on the instrument.

  • High-resolution instruments (Orbitrap, Q-TOF) commonly report accuracy in parts per million. For a 1,400 Da peptide, 5 ppm is about 0.007 Da.
  • Lower-resolution instruments, including many single-quadrupole LC-MS systems, report to roughly ±0.5 to ±1 Da and often quote average rather than monoisotopic mass.

When reading a result, check three things: whether the reported value is monoisotopic or average, which ion it refers to ([M+H]+, a deconvoluted neutral mass, or a specific charge state), and whether the difference from theory is smaller than the stated tolerance. A COA that says only “conforms” without the observed value gives you less to verify.

What can a mass spec result not tell you?

Mass spectrometry confirms that the expected molecule is present. It does not confirm that nothing else is present, and it is not quantitative without calibration standards.

  • It is not purity. Ionisation efficiency varies between molecules, so peak heights in an MS spectrum do not translate into percentages. Purity comes from HPLC-UV.
  • It cannot separate isomers. A peptide with two residues swapped, or with a D-amino acid in place of an L-amino acid, has exactly the same mass. Sequence confirmation needs MS/MS fragmentation or other methods.
  • It does not measure content. Water, counterions and salts are not reported, so MS says nothing about how much peptide is in a vial by weight.
  • It does not test endotoxin or sterility. Those are separate assays.

Not every certificate includes mass spectrometry. Soraci’s current certificates report HPLC purity, quantity and endotoxin results, and you can view them on our certificates of analysis page. Where a lab protocol requires identity confirmation, independent LC-MS testing of a retained aliquot is the standard approach.

How can you use mass spec data to verify a peptide supplier?

Ask for the raw spectrum, not just a pass statement, and check it against your own calculation. A practical sequence:

  1. Calculate the theoretical monoisotopic and average mass from the published sequence and any terminal modifications.
  2. Identify which ion the report quotes and convert it to a neutral mass.
  3. Confirm the lot number on the spectrum matches the lot on the vial and the HPLC report.
  4. Look for peaks at the shifts in the table above and ask how they were assessed.
  5. Read the MS alongside the HPLC chromatogram: a single dominant HPLC peak plus the correct mass is a much stronger combination than either alone.

Product-specific sequences and literature summaries are collected in our research library, and individual compound pages such as BPC-157 link to the lot certificates.

Frequently asked questions

Is mass spectrometry the same as HPLC purity?

No. HPLC with UV detection estimates purity by comparing peak areas. Mass spectrometry confirms identity by measuring mass-to-charge ratio. A full picture of a peptide lot uses both.

What does [M+H]+ mean on a peptide mass spec report?

It is the peptide’s neutral mass (M) plus one proton, about 1.007 Da, giving a singly charged ion. [M+2H]2+ means two protons were added, so the m/z value is roughly half the mass.

Why is my observed mass 22 units higher than expected?

A peak about 21.98 above [M+H]+ is almost always a sodium adduct, where sodium replaces a proton. It is a common background signal and does not by itself indicate an impurity.

Should I compare monoisotopic or average mass?

Use monoisotopic mass when the spectrum resolves individual isotope peaks, which is typical for peptides under about 3,000 Da on modern instruments. Use average mass when the report or instrument does not resolve isotopes.

Can mass spectrometry detect a wrong amino acid order?

Not from the intact mass alone, because rearranged sequences have identical mass. Tandem mass spectrometry (MS/MS), which fragments the peptide and reads the fragment ladder, is needed to confirm sequence order.

References

  1. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64–71. PubMed 2675315
  2. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry. 1988;60(20):2299–2301. doi:10.1021/ac00171a028
  3. D’Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014;101:2–30. PubMed 25044089
  4. Keller BO, Sui J, Young AB, Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Analytica Chimica Acta. 2008;627(1):71–81. doi:10.1016/j.aca.2008.04.043

All Soraci Labs products are sold for laboratory, analytical and research purposes only. They are not intended for human consumption, medical use, diagnostic use, or the treatment of any disease or condition.

Leave a Reply

Your email address will not be published. Required fields are marked *